DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Robert Galbraith - 1 Abiel Garcia - 1 John Kness - 1 Donald Trump - 1 Garcia - 1 Evan Seigerman - 1 Lina Khan - 1 Cowen - 1
Top related locs:
South San Francisco , California Amgen Kesselman Ireland U.S Puerto Rico United States Irish
Top related orgs:
REUTERS - 1 U.S . Federal Trade - 1 Horizon Therapeutics - 1 U.S - 1 District - 1 Federal - 1 Activision - 1 Horizon - 1

Search resuls for: "John Kness"


2 mentions found


☆ Analysis: FTC settlement could shelter Amgen from US price cuts, taxes
  + stars: | 2023-09-05 | by ( Deena Beasley | ) www.reuters.com   time to read: +5 min
An Amgen sign is seen at the company's office in South San Francisco, California October 21, 2013. With Horizon, Amgen acquires drugs that won't be affected by new U.S. negotiation requirements for blockbuster medications as well as possible tax advantages stemming from Horizon's headquarters in Ireland. Analysts said the Horizon deal could also help Amgen's tax situation. The United States has largely eliminated once-lucrative corporate tax benefits for pharmaceutical manufacturing operations in Puerto Rico, a U.S. territory. Horizon offers Amgen "potentially a better tax jurisdiction related to Irish manufacturing plants ... Amgen has a new manufacturing process they could potentially move there," Cowen's Werber said.
Persons: Robert Galbraith, Abiel Garcia, John Kness, Donald Trump, Garcia, Evan Seigerman, Lina Khan, Cowen, Biden, Michael Yee, Amgen, Cowen's Werber, Deena Beasley, Peter Henderson, Paul Simao Organizations: REUTERS, U.S . Federal Trade, Horizon Therapeutics, U.S, District, Federal, Activision, Horizon, Amgen, BMO Capital Markets, FTC, Reuters, U.S . Food, Drug Administration, Jefferies, Medicare, Internal Revenue Service, United, Thomson Locations: South San Francisco , California, Amgen, Kesselman, Ireland, U.S, Puerto Rico, United States, Irish
☆ FTC effort to stop Amgen's Horizon takeover faces uphill fight
  + stars: | 2023-05-18 | by ( Diane Bartz | Thomson Reuters | Focused On U.S. Antitrust As Well As Corporate Regulation | ) www.reuters.com   time to read: +4 min
That would appear to contradict the FTC's practice of preventing companies from using market power to push up prices. The FTC lawsuit spurred concern among investors who had brushed off the antitrust risk in Amgen's deal because of its limited business overlap with Horizon. "Our complaint is firmly rooted in longstanding antitrust law and we look forward to making our argument in court," an FTC spokesperson said. AMGEN OFFERS REMEDYAmgen said on Tuesday it had made an offer to the FTC in hopes of resolving the issue. "These are valid concerns that FTC has raised but what a court will do about it is uncertain," he said.
0 next >>
Total: 2